Nicole Cordes

Title: Nicole Cordes: Innovator in T Cell Transduction

Introduction

Nicole Cordes is a prominent inventor based in Bergisch Gladbach, Germany. She has made significant contributions to the field of immunotherapy, particularly in the transduction of T cells in the presence of malignant cells. Her innovative approach aims to enhance the efficiency of T cell therapies while minimizing the impact on malignant cells.

Latest Patents

Nicole Cordes holds a patent for a method titled "Method for transduction of T cells in the presence of malignant cells." This invention provides an in-vitro method of reducing the efficiency of transducing malignant cells of the blood system of a subject that are not derived from T cells with lentiviral vector particles. Importantly, this method does not compromise the efficiency of transducing T cells in a sample that includes both T cells and malignant cells. The patent outlines a combination of compositions that include transduced T cells expressing a CAR (chimeric antigen receptor) and non-transduced malignant cells, along with a tagged polypeptide that binds specifically to an antigen on the surface of the malignant cells.

Career Highlights

Nicole Cordes is associated with Miltenyi Biotec B.V. & Co. KG, a company known for its advancements in cell and gene therapy technologies. Her work focuses on developing innovative solutions that improve the efficacy of T cell therapies, contributing to the ongoing evolution of cancer treatment.

Collaborations

Nicole collaborates with notable colleagues such as Thomas Schaser and Andrew Kaiser. Their combined expertise enhances the research and development efforts within their field.

Conclusion

Nicole Cordes is a trailblazer in the realm of T cell transduction, with her patent reflecting a significant advancement in cancer therapy. Her work at Miltenyi Biotec and collaborations with esteemed colleagues underscore her commitment to innovation in medical science.